In vitro studies have shown that human prostate cancer (DU-145) and breast cancer (MCF-7) cells lines indeed express a higher amount of CYP3A4 protein in response to treatment with docetaxel [99, 100]. Here, CYP3A4 is linked to breast carcinoma.